phs000007.v30.p11 Framingham Cohort | Versions 1-30: passed embargo
| VDAS | 15154 | Longitudinal | | HuGeneFocused50K_Affy Mapping250K_Nsp Mapping250K_Sty Mapping50K_Hind240 Mapping50K_Xba240
|
phs000280.v5.p1 Atherosclerosis Risk in Communities (ARIC) Cohort | Versions 1-5: passed embargo
| VDAS | 15678 | Longitudinal, Cohort | | |
phs000577.v1.p1 UCDC Longitudinal Study | Version 1: passed embargo
| VDAS | 542 | Longitudinal | Links | |
phs000285.v3.p2 CARDIA Cohort | Versions 1-3: passed embargo
| VDAS | 3622 | Longitudinal | Links | |
phs000090.v4.p1 GENEVA: The Atherosclerosis Risk in Communities (ARIC) Study | Versions 1-4: passed embargo
| VDAS | 12771 | Case-Control | | AFFY_6.0
|
phs000228.v4.p1 HMP Core Microbiome Sampling Protocol A (HMP-A) | Versions 1-4: passed embargo
| VDAS | 300 | Population-Based Control Set | Links | 454 GS FLX Titanium 454 GS FLX Titanium
|
phs000835.v7.p1 Single Cell Analysis Program - Transcriptome (SCAP-T) (U. Penn) | Versions 1-7: passed embargo
| VDAS | 38 | Case Set | Links | HiSeq 2500 NextSeq 500
|
phs000086.v3.p1 DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes | Versions 1-3: passed embargo
| VDAS | 1497 | Clinical Trial, Longitudinal | Links | HumanHap550v3.0 ILLUMINA_Human_1M
|
phs000309.v3.p2 The CARDIA-GENEVA Study | Versions 1-3: passed embargo
| VDAS | 1926 | Longitudinal | Links | AFFY_6.0
|
phs000605.v1.p1 Multicenter International Lymphangioleiomyomatosis Efficacy of Sirolimus Trial (The MILES Trial) | Version 1: passed embargo
| VDAS | 111 | Clinical Trial, Clinical Diagnostic Testing, Randomized Controlled Clinical Trial | Links | |
phs000575.v1.p1 PWS Natural History Protocol | Version 1: passed embargo
| VDAS | 200 | Case Set | | |
phs001419.v1.p1 INC Natural History Study | Version 1: passed embargo
| VDAS | 1002 | Longitudinal | Links | |
phs000596.v1.p1 Longitudinal Study of PCD: 5-18 Years of Age | Version 1: passed embargo
| VDAS | 124 | Longitudinal | | |
phs000850.v1.p1 OPPERA prospective cohort study of first-onset TMJD | Version 1: passed embargo
| VDAS | 3258 | Prospective, Cohort, Longitudinal | Links | Algynomics Pain Research Panel
|
phs000697.v1.p1 Effects of Antithymocyte Globulin in Adults With Myelodysplastic Syndrome | Version 1: passed embargo
| VDAS | 39 | Clinical Trial, Interventional | Links | |
phs000762.v1.p1 OPPERA baseline case-control study of chronic TMJD | Version 1: passed embargo
| VDAS | 1818 | Case-Control | Links | Algynomics Pain Research Panel
|
phs000378.v1.p1 Indianapolis-Ibadan, Nigeria Comparative Epidemiological Study of Dementia | Version 1: passed embargo
| VDAS | 1251 | Community, Longitudinal, Cross-Sectional | Links | HumanOmni2.5
|
phs000200.v12.p3 Women's Health Initiative | Versions 1-11: passed embargo Version 12:
| VDAS | 143213 | Partial Factorial Randomized, Double-Blind, Placebo-Controlled, Cohort, Longitudinal | Links | |
phs000594.v1.p1 A Phase 2 Study of Tipifarnib in Large Granular Lymphocyte (LGL) Leukemia | Version 1: passed embargo
| VDAS | 9 | Interventional, Clinical Trial | Links | |
phs000001.v3.p1 NEI Age-Related Eye Disease Study (AREDS) | Versions 1-3: passed embargo
| VDAS | 4757 | Case-Control | Links | ILMN_Human-1 Mapping50K_Hind240 Mapping50K_Xba240
|